262 related articles for article (PubMed ID: 17299602)
1. The effects of antidepressants on the hypothalamic-pituitary-adrenal axis.
Mason BL; Pariante CM
Drug News Perspect; 2006 Dec; 19(10):603-8. PubMed ID: 17299602
[TBL] [Abstract][Full Text] [Related]
2. [The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression].
Juruena MF; Cleare AJ; Pariante CM
Braz J Psychiatry; 2004 Sep; 26(3):189-201. PubMed ID: 15645065
[TBL] [Abstract][Full Text] [Related]
3. In vitro modulation of the glucocorticoid receptor by antidepressants.
Carvalho LA; Pariante CM
Stress; 2008 Nov; 11(6):411-24. PubMed ID: 19065455
[TBL] [Abstract][Full Text] [Related]
4. Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment.
Calfa G; Kademian S; Ceschin D; Vega G; Rabinovich GA; Volosin M
Psychoneuroendocrinology; 2003 Jul; 28(5):687-701. PubMed ID: 12727135
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
Pariante CM; Miller AH
Biol Psychiatry; 2001 Mar; 49(5):391-404. PubMed ID: 11274650
[TBL] [Abstract][Full Text] [Related]
6. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.
Barden N
J Psychiatry Neurosci; 2004 May; 29(3):185-93. PubMed ID: 15173895
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids.
Pariante CM
Ann N Y Acad Sci; 2009 Oct; 1179():144-52. PubMed ID: 19906237
[TBL] [Abstract][Full Text] [Related]
8. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
Nikisch G
Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
[TBL] [Abstract][Full Text] [Related]
9. Chronic activation of NPFFR2 stimulates the stress-related depressive behaviors through HPA axis modulation.
Lin YT; Liu TY; Yang CY; Yu YL; Chen TC; Day YJ; Chang CC; Huang GJ; Chen JC
Psychoneuroendocrinology; 2016 Sep; 71():73-85. PubMed ID: 27243477
[TBL] [Abstract][Full Text] [Related]
10. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats.
Butterweck V; Winterhoff H; Herkenham M
Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of depression-like behavior to glucocorticoids and antidepressants is independent of forebrain glucocorticoid receptors.
Vincent MY; Hussain RJ; Zampi ME; Sheeran K; Solomon MB; Herman JP; Khan A; Jacobson L
Brain Res; 2013 Aug; 1525():1-15. PubMed ID: 23727405
[TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour.
Harris AP; Holmes MC; de Kloet ER; Chapman KE; Seckl JR
Psychoneuroendocrinology; 2013 May; 38(5):648-58. PubMed ID: 22980941
[TBL] [Abstract][Full Text] [Related]
13. Early life stress in depressive patients: role of glucocorticoid and mineralocorticoid receptors and of hypothalamic-pituitary-adrenal axis activity.
Juruena MF; Werne Baes CV; Menezes IC; Graeff FG
Curr Pharm Des; 2015; 21(11):1369-78. PubMed ID: 25564387
[TBL] [Abstract][Full Text] [Related]
14. Stress responsive neurohormones in depression and anxiety.
Ströhle A; Holsboer F
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
[TBL] [Abstract][Full Text] [Related]
15. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.
Keller J; Gomez R; Williams G; Lembke A; Lazzeroni L; Murphy GM; Schatzberg AF
Mol Psychiatry; 2017 Apr; 22(4):527-536. PubMed ID: 27528460
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary-adrenocortical axis hypersensitivity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.
Milutinović DV; Macut D; Božić I; Nestorov J; Damjanović S; Matić G
Exp Clin Endocrinol Diabetes; 2011 Nov; 119(10):636-43. PubMed ID: 22068557
[TBL] [Abstract][Full Text] [Related]
18. Extent of cortisol suppression at baseline predicts improvement in HPA axis function during antidepressant treatment.
Scherf-Clavel M; Wurst C; Nitschke F; Stonawski S; Burschka C; Friess L; Unterecker S; Hommers L; Deckert J; Domschke K; Menke A
Psychoneuroendocrinology; 2020 Apr; 114():104590. PubMed ID: 32006918
[TBL] [Abstract][Full Text] [Related]
19. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[TBL] [Abstract][Full Text] [Related]
20. The glucocorticoid receptor: part of the solution or part of the problem?
Pariante CM
J Psychopharmacol; 2006 Jul; 20(4 Suppl):79-84. PubMed ID: 16785275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
